Monalisa Soft Dermal Filler
Hybrid cross-linked hyaluronic acid filler with 23mg/mL concentration and 0.05 EU/mL endotoxin levels. Clinically proven to maintain 89% volume retention at 12 months (n=152).
Advanced Cross-linking Technology
Utilizing Hyacrossâ„¢ technology with optimal 6% cross-linking ratio for natural viscoelastic properties (G’ 250Pa, G” 85Pa). Particle size distribution of 300-500μm ensures smooth tissue integration. Contains 98.5% pure HA from biofermentation process.
Clinical Performance
Safety Profile
0.12% adverse event rate in Phase III trials (n=842), 97% patient satisfaction at 6mo
Longevity
Maintains 78% correction at 9 months post-treatment in perioral areas
Precision
0.3mm cannula-compatible for micro-droplet technique in periocular zones
Technical Specifications
- Concentration: 23mg/mL HA
- Needles: 2 x 30G 1/2″
- Cross-linker: BDDE-free
- pH: 7.2-7.6
- Storage: 2-25°C
Clinical Protocol
- Depth: Mid-dermal placement (1.5-2.5mm)
- Volume: 0.05-0.1mL/cm² for fine lines
- Technique: Serial puncture or linear threading
- Anesthesia: 25G cannula with lidocaine 1%
Recommended Indications
Periocular Zone
Under-eye hydration: 0.2-0.3mL per side using 32G needle. Maintain 3mm safety margin from orbital rim.
Perioral Area
Lip border definition: 0.4-0.6mL total dose. Use vertical injection technique for vermilion enhancement.
Décolleté Rejuvenation
Cross-hatching technique with 1mL total volume. 25G cannula recommended for vascular safety.
Clinical Notice
Important: Results may vary based on individual tissue characteristics and injection technique. For use by licensed medical professionals only. Contraindicated in pregnancy and active skin infections.
Avoid vascular territories using proper anatomical knowledge. Have hyaluronidase readily available. Post-treatment edema typically resolves within 72 hours.
Reviews
There are no reviews yet.